Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Baclofen for the Treatment of Alcohol Dependence and Possible Role of Comorbid Anxiety
Kirsten C. Morley, Andrew Baillie, S. Leung, et al.
Alcohol and Alcoholism (2014) Vol. 49, Iss. 6, pp. 654-660
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Elizabeth M. Burnette, Steven J. Nieto, Erica N. Grodin, et al.
Drugs (2022) Vol. 82, Iss. 3, pp. 251-274
Open Access | Times Cited: 110
Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: A systematic review and meta-analysis
Mimi Pierce, Arjen L. Sutterland, Esther M. Beraha, et al.
European Neuropsychopharmacology (2018) Vol. 28, Iss. 7, pp. 795-806
Closed Access | Times Cited: 152
Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta‐analysis
Abigail K. Rose, Andrew Jones
Addiction (2018) Vol. 113, Iss. 8, pp. 1396-1406
Closed Access | Times Cited: 128
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
Lara A. Ray, Spencer Bujarski, Erica N. Grodin, et al.
The American Journal of Drug and Alcohol Abuse (2018) Vol. 45, Iss. 2, pp. 124-140
Open Access | Times Cited: 114
Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial
Kirsten C. Morley, Andrew Baillie, I.S. Fraser, et al.
The British Journal of Psychiatry (2018) Vol. 212, Iss. 6, pp. 362-369
Open Access | Times Cited: 102
Baclofen for alcohol use disorder
Roberta Agabio, Rosella Saulle, Susanne Rösner, et al.
Cochrane library (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 27
Medications for alcohol use disorders: An overview
Mohammed Akbar, Mark Egli, Young‐Eun Cho, et al.
Pharmacology & Therapeutics (2017) Vol. 185, pp. 64-85
Open Access | Times Cited: 86
Potential Medications for the Treatment of Alcohol use Disorder: An Evaluation of Clinical Efficacy and Safety
Raye Z. Litten, Bonnie B. Wilford, Daniel E. Falk, et al.
Substance Abuse (2016) Vol. 37, Iss. 2, pp. 286-298
Closed Access | Times Cited: 82
Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision
Michael Soyka, Henry R. Kranzler, Victor Hesselbrock, et al.
The World Journal of Biological Psychiatry (2016) Vol. 18, Iss. 2, pp. 86-119
Closed Access | Times Cited: 73
The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective
Renaud de Beaurepaire, Julia Sinclair, Mathis Heydtmann, et al.
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 70
Baclofen for alcohol use disorder
Silvia Minozzi, Rosella Saulle, Susanne Rösner
Cochrane library (2018) Vol. 2018, Iss. 11
Open Access | Times Cited: 66
Baclofen for alcohol use disorder—a systematic meta‐analysis
Tom Bschor, Jonathan Henssler, Martín Müller, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 138, Iss. 3, pp. 232-242
Closed Access | Times Cited: 66
Review article: pharmacotherapy for alcohol dependence – the why, the what and the wherefore
ET Goh, Marsha Y. Morgan
Alimentary Pharmacology & Therapeutics (2017) Vol. 45, Iss. 7, pp. 865-882
Open Access | Times Cited: 65
Baclofen in the treatment of alcohol use disorder: tailored doses matter
Renaud de Beaurepaire, Philippe Jaury
Alcohol and Alcoholism (2024) Vol. 59, Iss. 2
Open Access | Times Cited: 7
Astrocytic GABAergic Regulation in Alcohol Use and Major Depressive Disorders
Dina Ali, H. Mokdad Ali, Matthew R. Lopez, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 318-318
Open Access | Times Cited: 6
Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence
Julia Sinclair, Sophia E. Chambers, Celia J. Shiles, et al.
Drug Safety (2016) Vol. 39, Iss. 7, pp. 627-645
Open Access | Times Cited: 55
Biobehavioral effects of baclofen in anxious alcohol-dependent individuals: a randomized, double-blind, placebo-controlled, laboratory study
Mehdi Farokhnia, Melanie L. Schwandt, M R Lee, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 4, pp. e1108-e1108
Open Access | Times Cited: 50
Drug-drug interactions in the treatment for alcohol use disorders: A comprehensive review
Simona Guerzoni, Lanfranco Pellesi, Luigi Alberto Pini, et al.
Pharmacological Research (2018) Vol. 133, pp. 65-76
Open Access | Times Cited: 48
National trends in alcohol pharmacotherapy: Findings from an Australian claims database
Kirsten C. Morley, Warren Logge, Sallie‐Anne Pearson, et al.
Drug and Alcohol Dependence (2016) Vol. 166, pp. 254-257
Closed Access | Times Cited: 47
Pharmacological Treatments for Alcohol Use Disorder: Considering the Role of Sex and Gender
Dylan Kirsch, Malia A. Belnap, Elizabeth M. Burnette, et al.
Current Addiction Reports (2024) Vol. 11, Iss. 1, pp. 81-93
Closed Access | Times Cited: 5
The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders
Daniel Peterlik, Peter J. Flor, Nicole Uschold‐Schmidt
Current Neuropharmacology (2015) Vol. 14, Iss. 5, pp. 514-539
Open Access | Times Cited: 49
A Review of the Potential Mechanisms of Action of Baclofen in Alcohol Use Disorder
Renaud de Beaurepaire
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 41
The influence of anxiety symptoms on clinical outcomes during baclofen treatment of alcohol use disorder: A systematic review and meta-analysis
Roberta Agabio, David S. Baldwin, Hugo Amaro, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 296-313
Open Access | Times Cited: 27
Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
Pascal Valentin Fischler, Michael Soyka, Erich Seifritz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
The neurobehavioural effects of cannabidiol in alcohol use disorder: study protocol for a double-blind, randomised, cross over, placebo-controlled trial
Tristan Hurzeler, Warren Logge, Joshua Watt, et al.
Contemporary Clinical Trials Communications (2024) Vol. 41, pp. 101341-101341
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top